Aptamers for use in the treatment of Coronaviridae infections
AssigneeAPTA Therapeutics GmbH
InventorsAnnekathrin Haberland, Johannes Müller, Gerd Wallukat, Peter Göttel
Life of this patent
Estimating the term…
Abstract
The present invention relates to new aptamer molecules for use in therapy of infections caused by viruses from the Coronaviridae family, a method of preventing infection caused by viruses from the Coronaviridae family in vitro/ex vivo, a pharmaceutical composition and a kit comprising such aptamer molecules, and the use of aptamer molecules for preventing infection of somatic cells with a virus from the Coronaviridae family. The present invention also relates to affinity molecules binding to specific and newly identified epitopes of a key enzyme of Coronaviridae viruses.
Claims7
A method of treating a cell infected with a SARs-CoV-2 virus comprising, administering to the cell an effective amount of an aptamer comprising the nucleic acid sequence of SEQ ID NO:
- 1 (GGT TGG TGT GGT TGG).
Dependencies are inferred from the claim text.